How we score →

Musely (FaceRx) Review

✓ Updated July 2026 By the TelehealthIndex Editorial Team · How we score Fair · #6 in Hair Loss & Dermatology
Advertising Disclosure: TelehealthIndex is reader-supported. If you sign up with a provider through links on this page, we may earn a commission at no extra cost to you. Commissions never influence our scores or rankings — several of our top-rated providers pay us nothing. How we score → · Full disclosure →

Musely score

Fair · #6 in Hair Loss & Dermatology · Data as of July 2026
Clinical credibilityLimited
Regulatory & safety recordNotable deductions
Transparency & trustWeak
Access & coverageMixed
Customer experienceGood
Value & pricingMixed
Pillar ratings are qualitative summaries of our internal rubric; we do not publish the point weights. Read the full methodology →

TelehealthIndex scores and rankings are editorial opinions resulting from our selection, weighting, and interpretation of the factors described in our methodology.

What it is

Dermatologist-only async platform for compounded melasma/anti-aging/hair creams; own 503A pharmacies; 1.2M+ patients.

Strengths

  • Available nationwide (50 states)

Considerations

  • High-strength compounded hydroquinone (6-12% vs 4% standard) draws legitimate dermatologist safety criticism
  • Active website-wiretap privacy class action (arbitration motion denied 2025)
  • Restrictive money-back guarantee (daily app check-ins required)
Note: this provider offers compounded medications for one or more services. Compounded medications are not FDA-approved.
Founded2013
OwnershipPrivate (Trusper Inc.)
AvailabilityNationwide (50 states)
InsuranceNo
Money-back guaranteeNot advertised
Pricing$20 visit; treatments ~$27-99/mo equivalent; subscription saves ~30%
Visit Musely We may earn a commission — disclosure.

Alternatives to consider

Happy Head Fair · #5 in Hair Loss & Dermatology — read review → Dermatica Fair · #7 in Hair Loss & Dermatology — read review →

Data as of July 19, 2026. Scores are editorial opinions reflecting documented business practices, transparency, pricing, access, and nonclinical consumer-service factors — not clinical quality or outcomes. Found an error? Report it →